Institut universitaire en santé mentale de Montréal is a psychiatric hospital in Montreal, Quebec, Canada. It is located at 7401 Hochelaga Street in the borough of Mercier–Hochelaga-Maisonneuve. It was established in 1873 and is affiliated with the Université de Montréal Faculty of Medicine.

There are 389 beds in Centre de recherche Fernand-Seguin.

During the past decade, Centre de recherche Fernand-Seguin conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de recherche Fernand-Seguin" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Yale University" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centre de recherche Fernand-Seguin" are "Psychotic Disorders" (3 trials), "Major Depression" (2 trials), "Schizophrenia" (2 trials), "Anxiety Depression" (1 trials) and "Auditory Hallucination, Verbal" (1 trials). Many other conditions were trialed in "Centre de recherche Fernand-Seguin" in a lesser frequency.

Most popular intervention types in "Centre de recherche Fernand-Seguin" are "Behavioral" (4 trials), "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Avatar Therapy" (1 trials), "Cognitive Behavioral Therapy" (1 trials), "Cognitive behavior therapy" (1 trials), "Cognitive remediation therapy (CR)" (1 trials) and "Control Group (pharmacotherapy and/or psychotherapy, n=10)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de recherche Fernand-Seguin" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Centre de recherche Fernand-Seguin". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre de recherche Fernand-Seguin, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de recherche Fernand-Seguin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".